期刊文献+

5-氟尿嘧啶联合米非司酮对人宫颈癌SiHa细胞增殖的影响及作用机制研究 被引量:2

Effect of 5-fluorouracil combined with mifepristone on cell proliferation of human cervical cancer cell line SiHa and its mechanism
原文传递
导出
摘要 目的:体外研究5-氟尿嘧啶(5-fluororacil,5-Fu)联合米非司酮(mifepristone,MIF)对人宫颈癌SiHa细胞株的增殖抑制作用及可能的作用机制。方法:体外培养人宫颈鳞癌SiHa细胞株,采用MTT法检测不同浓度MIF、5-Fu单药以及两药联合作用对SiHa细胞增殖率的影响;采用FCM分析两药合用对SiHa细胞凋亡率及细胞周期分布影响;蛋白质印迹法检测药物处理后SiHa细胞中p53、Bax和Bcl-2蛋白表达的变化。结果:不同浓度5-Fu和MIF单药对SiHa细胞增殖均有抑制作用(P<0.05),且呈浓度和时间依赖性。5-Fu联合MIF作用于SiHa细胞可增强5-Fu对SiHa细胞的增殖抑制(P<0.05),且对MIF的作用浓度呈剂量依赖作用;蛋白质印迹法检测结果显示,联合用药组能使p53和Bax蛋白表达上调,Bcl-2蛋白表达下调,呈浓度依赖性。结论:MIF能增强5-Fu对SiHa细胞的增殖抑制和诱导凋亡作用,其机制可能与上调p53和Bax蛋白,下调Bcl-2蛋白表达有关。 Objective: To investigate the inhibitory effect of 5-fluorouracil (5-Fu) combined with mifepristone (MIF) on the cell proliferation of human cervical cancer cell line SiHa in vitro, and to explore the possible mechanism. Methods: SiHa cells were cultured in vitro. The proliferation inhibitory rates of SiHa cells treated with different concentrations of MIF or 5-Fu alone and the combination of MIF and 5-Fu were detected by MTT assay. The changes of apoptosis rate and the cell cycle of SiHa cells were determined by flow cytometry. The expression levels of p53, Bcl-2 and Bax proteins in SiHa cells were examined by Western blotting. Results: Different concentrations of MIF or 5-Fu could inhibit the proliferation of SiHa cells in a dose- and time-dependent manner (P0.05). 5-Fu in combination with different concentrations of MIF could significantly enhance this inhibitory effect (P0.05) in a dose-dependent manner. The expression levels of p53 and Bax proteins were increased while the expression level of Bcl-2 protein was decreased in SiHa cells after treatment with 5-Fu plus MIF, and these effects were in a dose-dependent manner. Conclusion: MIF can enhance the inhibitory effect of 5-Fu on SiHa cells, and promote the apoptosis of SiHa cells induced by 5-Fu. The mechanism may be associated with the down-regulation of Bcl-2 protein and up-regulation of p53 and Bax proteins.
作者 李彩虹 叶红
出处 《肿瘤》 CAS CSCD 北大核心 2011年第8期718-722,共5页 Tumor
关键词 宫颈肿瘤 米非司酮 氟尿嘧啶 抗肿瘤联合化疗方案 SIHA细胞 Uterine cervical neoplasms Mifepristone Fluorouracil Antineoplastic combined chemotherapy protocols SiHa cells
  • 相关文献

参考文献11

  • 1ROCERETO T F, BRADY W E, SHAHIN M S, et al.A phase Ⅱ evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study [J]. Gynecol Oncol, 2010, 116(3): 332-334.
  • 2KOIVISTO-KORANDER R, LEMINEN A, HEIKINHEIMO O. Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma[J]. Obstet Gynecol, 2007, 109(2 Pt 2): 512-514.
  • 3WAGNER E, KIRCHEIS R, WALKER G F. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy [J]. Biomed Pharmacother, 2004, 58(3): 152-161.
  • 4TORTORA G, BIAMCO R, DANIELE G, et al. Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies[J]. Drug Resist Updates, 2007, 10(3): 81-100.
  • 5TAMM I, SCHRIEVER F, DORKEN B. Apoptosis implications of basic research for clinical oncology[J]. Lancet Oncol, 2001, 2(1): 33-42.
  • 6SCHAFF E A. Mifepristone: ten years later [J]. Contraception, 2010, 81 (1): 1-7.
  • 7HYDER S M, CHIAPPETTA C, STANCEL G M. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells[J]. Int J Cancer, 2001, 92(4): 469-473.
  • 8LIANG Y, HOU M, KALLAB A M, et al. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGF betal[J]. Int J Oncol, 2003, 23(2): 369-380.
  • 9苏建家,欧盛敬,李瑗,欧超,段小娴,曹骥,杨春,岳惠芬,班克臣.树鼩实验性肝癌形成过程Bax、bcl-2的动态表达与细胞凋亡[J].肿瘤,2004,24(5):433-436. 被引量:3
  • 10LOWE S W, RULEY HE, JACKS T, et al. p53- dependent apoptosis modulates the cytotoxicity of anticancer drugs[J]. Cell, 1993, 74(6): 957-967.

二级参考文献5

共引文献2

同被引文献27

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部